KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$163.1 million.

  • Vir Biotechnology's Consolidated Net Income rose 2366.49% to -$163.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$499.7 million, marking a year-over-year increase of 631.69%. This contributed to the annual value of -$522.0 million for FY2024, which is 1514.46% up from last year.
  • As of Q3 2025, Vir Biotechnology's Consolidated Net Income stood at -$163.1 million, which was up 2366.49% from -$111.0 million recorded in Q2 2025.
  • Vir Biotechnology's 5-year Consolidated Net Income high stood at $525.3 million for Q4 2021, and its period low was -$213.7 million during Q3 2024.
  • Over the past 5 years, Vir Biotechnology's median Consolidated Net Income value was -$111.0 million (recorded in 2025), while the average stood at -$25.7 million.
  • As far as peak fluctuations go, Vir Biotechnology's Consolidated Net Income soared by 54975.38% in 2021, and later tumbled by 22374.9% in 2022.
  • Vir Biotechnology's Consolidated Net Income (Quarter) stood at $525.3 million in 2021, then crashed by 119.34% to -$101.6 million in 2022, then fell by 14.14% to -$116.0 million in 2023, then rose by 9.82% to -$104.6 million in 2024, then crashed by 55.98% to -$163.1 million in 2025.
  • Its last three reported values are -$163.1 million in Q3 2025, -$111.0 million for Q2 2025, and -$121.0 million during Q1 2025.